Clinical Trial Update: Omega-3 Fatty Acids Supplementation in ADHD [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating omega-3 fatty acid supplementation for attention-deficit/hyperactivity disorder has been terminated. The update provides no published r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: ADHD | Phase 3 | Status: TERMINATED